SCHEMBL24686227

SCHEMBL24686227

c1ccc2cc(-c3ccc(-c4nc(-c5ccc(-c6ccc7ccccc7c6)cc5)nc(-c5ccc(-c6cc7ccccc7c7ccccc67)cc5)n4)cc3)ccc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 2/20 0.46
▸ ESR1 P03372 1/20 0.46
▸ ESR2 Q92731 1/20 0.46
▸ GSTP1 P09211 1/20 0.42
▸ ALDH1A1 P00352 4/20 0.41
▸ CYP1A2 P05177 3/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ TP53 P04637 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ GPR84 Q9NQS5 2/20 0.41
▸ CYP17A1 P05093 1/20 0.41
▸ CYP19A1 P11511 1/20 0.41
▸ CYP11B2 P19099 1/20 0.41
▸ ALOX5 P09917 1/20 0.41
▸ SRC P12931 1/20 0.41
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25796483 0.97 CYP11B1 (0.47) CYP11B1ESR1ESR2GSTP1ALDH1A1
SCHEMBL23633686 0.97 CYP11B1 (0.47) CYP11B1ESR1ESR2GSTP1ALDH1A1
SCHEMBL26632982 0.93 ESR1 (0.46) CYP11B1ESR1ESR2GSTP1ALDH1A1
SCHEMBL24307000 0.92 ESR1 (0.44) CYP11B1ESR1ESR2GSTP1ALDH1A1
SCHEMBL17932625 0.90 MEN1 (0.46) CYP11B1ESR1ESR2GSTP1ALDH1A1
SCHEMBL25478760 0.90 CYP1A1 (0.44) CYP11B1ESR1ESR2GSTP1ALDH1A1
SCHEMBL17932654 0.90 CYP11B1 (0.44) CYP11B1ESR1ESR2GSTP1ALDH1A1
SCHEMBL24306968 0.88 ALDH1A1 (0.42) CYP11B1ESR1ESR2GSTP1ALDH1A1
SCHEMBL23759303 0.88 HPRT1 (0.48) CYP11B1ESR1ESR2ALDH1A1CYP1A2
SCHEMBL26047132 0.88 HPRT1 (0.48) CYP11B1ESR1ESR2ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11469378-B2 Electroluminescent compound and electroluminescent device including the same LG DISPLAY CO., LTD. (KR) 2022-10-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11469378-B2 Electroluminescent compound and electroluminescent device including the same LEF1, CLCN2, PIEZO1 CYP11B1 873/4885ESR1 390/4885ESR2 358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback